The World Anti-Microbial Resistance Congress is the leading global conference on anti-microbial resistance. The event brings together government authorities, pharma, biotechs, diagnostics providers, hospitals, funding agencies, academia, laboratories and payers to discuss the urgent need for the development of novel and new classes of antibiotics, the application of responsible antimicrobial stewardship guidelines and the advances in diagnostics.
The world is now faced with an opportunity to curb Anti-Microbial Resistance while leveraging the benefits of an incentivized industry that can save millions of lives while transforming the way infectious diseases are treated. We are entering a new era of treating infectious diseases.
With funding for antibiotic R&D on the rise, the discussion now moves into the real incentives for the commercialization of antibiotics, the application of innovative diagnostics technologies and the collaboration between industry and physicians community to improve stewardship practices.
At the 4th Annual World Anti-Microbial Resistance Congress in October 2018, industry leaders, government authorities and the healthcare community from more than 30+ countries will join in Washington D.C. to address the key challenges and opportunities for curbing Anti-Microbial Resistance.
The 400+ conference attendees will be gathered at the Ritz-Carlton Hotel in Washington D.C. on October 25 and 26, 2018. With 4 tracks covering Antibiotic R&D, Diagnostics, Antimicrobial Stewardship, and Partnering & Funding for the development of new and non-traditional antibiotics, the 4th edition of the World Anti-Microbial Resistance Congress is set to be the most strategic AMR conference globally.
If your organization is working in the infectious disease space and has a solution to curb anti-microbial resistance, then you should be a part of the World Anti-Microbial Resistance Congress 2018!